(−)-Epothilone B
SIGMA/E2656 - from Sorangium cellulosum, ≥98% (HPLC)
Synonym: EPO906; EpoB; Patupilone
CAS Number: 152044-54-7
Empirical Formula (Hill Notation): C27H41NO6S
Molecular Weight: 507.68
MDL Number: MFCD02101921
Linear Formula: C27H41NO6S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| biological source | Sorangium cellulosum |
| color | white to off-white |
| form | lyophilized powder |
| InChI | 1S/C27H41NO6S/c1-15-9-8-1 |
| InChI key | QXRSDHAAWVKZLJ-PVYNADRNSA |
| Quality Level | 100 ![]() |
| SMILES string | [H][C@]1(C[C@]2([H])O[C@] |
| storage condition | desiccated |
| protect from light | |
| storage temp. | −20°C |
| Biochem/physiol Actions: | (-)-Epothilone B is a microtubule (MT) stabilizing drug and natural macrolide antitumor from myxobacteria Sorangium cellulosum. EpoB has similar biological properties to EpoA. However, EpoB is 10-fold more potent than EpoA against P-glycoprotein-expressing multidrug resistant (MDR) cells (IC50 = 2 nM for MDR CCRF-CEM/VBL100 cells). (-)-Epothilone B is similar to paclitaxel in binding displacement, and a substitution for paclitaxel in dependent cell growth. EpoB causes cell cycle arrest (IC50 = 3.5 nM). |
| Biochem/physiol Actions: | EpoB is a microtubule stabilizing drug and natural macrolide antitumor. |
| General description: | Epothilones has antimitotic properties. It prevents microtubule depolymerization and competitively blocks paclitaxel binding to microtubules. Epothilone B is used to treat metastatic breast cancer (MBC). |
| Packaging: | 1, 5 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |

